News

Vanda Pharmaceuticals is suing the FDA again, this time alleging the agency is unlawfully delaying a hearing to discuss the rejection of the biotech's stomach disorder drug last year. The FDA has ...
Vanda Pharmaceuticals (NASDAQ:VNDA) is alleging that members of the U.S. FDA "have committed to delay" its request for a hearing to discuss the agency's issuing of a Complete Response Letter in ...
WASHINGTON, May 5, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) informed Vanda that the New Drug ...
Vanda Pharmaceuticals reported its financial results for Q1 2025, revealing a revenue of $50 million, which fell short of the $61.02 million forecast. The company also reported a net loss of $29.5 ...
Vanda Pharmaceuticals reported its financial results for Q1 2025, revealing a revenue of $50 million, which fell short of the $61.02 million forecast. The company also reported a net loss of $29.5 ...
WASHINGTON, April 23, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. ("Vanda") (Nasdaq: VNDA) today announced that FDA bureaucrats have committed to delay Vanda's request for a hearing on the ...
The Vanda Miss Joaquim was born and bred in Singapore in 1893, in the garden of a woman named Agnes Joaquim, an Armenian horticulturist who lived in Tanjong Pagar.
SINGAPORE - Singapore-born giant panda Le Le, which returned to China in 2024, is now living a solitary existence after getting into a brawl with one of his enclosure mates. The incident occurred ...
Despite a 5% revenue increase, Vanda Pharmaceuticals Inc (VNDA) faces challenges with a significant net loss and rising operating expenses. WASHINGTON (AP) — Vanda Pharmaceuticals Inc. VNDA ...
If you’re driving around Los Angeles and you spot a giant Panda Express to go container, don’t be afraid to take a look inside. Just a few blocks away from USC, Panda Express is kicking off ...
The FDA has declined to approve Vanda Pharma's tradipitant for delayed gastric emptying (gastroparesis), prompting a furious response from the company. In a statement, the company says the FDA's ...